Syncope, Vasovagal Clinical Trial
Official title:
Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation
For a number of years, researchers have examined the effects of the muscle-tensing
technique, Applied Tension (AT), on blood donation-related vasovagal symptoms and donor
retention. AT was developed originally to reduce symptoms and avoidance behaviour in people
with strong fears of blood and needles (phobics). It was based on the idea that
exercise-related increases in blood pressure might be able to counteract the effects of
stimuli that lead to a decrease in delivery of blood to the brain. AT was adapted for
non-phobic blood donors and significant reductions in self-reported vasovagal symptoms and
the need for nurse-initiated treatment as well as increases in donor retention were observed
in some groups.
That said, individual response to AT is quite variable. This is probably related to recent
research indicating that exercise-related maintenance of heart rate and blood pressure plays
only a minor role in reducing vasovagal symptoms. Rather, AT appears to be working at least
in part by regulating breathing and reducing the possibility of hyperventilation. Pilot
results suggest that a novel intervention aimed specifically at breathing may be more
effective and reliable than traditional AT. To evaluate this idea, 408 blood donors at
mobile clinics in colleges and universities will be assigned randomly to four conditions. In
brief, 5-minute preparation sessions using a notebook computer, donors will either learn a
respiration control technique to avoid hyperventilation, AT, both, or neither. As a
manipulation check and also a means of examining mechanisms of the interventions, e.g., the
possibility that AT may work by regulating breathing and CO2, participants will wear
non-invasive portable capnometers while they are giving blood. Outcome will also be assessed
by self-report of vasovagal symptoms, observational data, and number of return visits to a
blood clinic in the following year verified by the provincial blood collection agency,
Héma-Québec. As a secondary aim, the research will examine possible moderating effects of
pre-donation anxiety and sex.
The development of simple, effective approaches to reduce vasovagal symptoms during blood
donation has the potential to improve the blood donation experience and blood donor
retention as well as encourage people who have never given blood to consider the procedure.
It will also improve medical and dental care more generally given the use of needles in so
many procedures.
Status | Recruiting |
Enrollment | 408 |
Est. completion date | May 31, 2018 |
Est. primary completion date | May 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 39 Years |
Eligibility |
Inclusion Criteria: - Healthy volunteer blood donors. Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
Canada | McGill University | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
McGill University | Canadian Institutes of Health Research (CIHR) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in End Tidal CO2 | assessed by ambulatory monitor (capnometer) | change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes) | |
Primary | Change in Respiration Rate | assessed by ambulatory monitor (capnometer) | change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes) | |
Primary | Blood Donation Reactions Inventory | questionnaire assessing presyncopal vasovagal symptoms | completed in the recovery area, approximately 15 minutes after blood donation | |
Primary | Research Assistant Observations | participant anxiety, fainting, whether or not treatment for a vasovagal response required, etc., noted by a research assistant | during blood donation | |
Secondary | Change in Spielberger State Anxiety Scale Score | self-report questionnaire | completed just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in anxiety | |
Secondary | Medical Fears Survey | self-report questionnaire | completed in the recovery area, approximately 15 minutes after blood donation | |
Secondary | Change in Systolic Blood Pressure | in mmHg | measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in blood pressure | |
Secondary | Change in Diastolic Blood Pressure | in mmHg | measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in blood pressure | |
Secondary | Change in Heart Rate | in bpm | measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in heart rate | |
Secondary | Blood Donor Return | number of times the donor returns to give blood again in a one-year time frame as reported by Hema-Quebec | one year after participating in the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05555771 -
Paediatric Syncope in the Emergency Department
|
N/A | |
Completed |
NCT06038708 -
Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
|
||
Not yet recruiting |
NCT05572034 -
Cardiac Autonomic Denervation for Cardio-inhibitory Syncope
|
N/A | |
Completed |
NCT05729724 -
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
|
||
Recruiting |
NCT04595942 -
Midodrine and Fludrocortisone for Vasovagal Syncope
|
Phase 3 | |
Completed |
NCT03903744 -
Cardioneuroablation for Reflex Syncope
|
N/A | |
Completed |
NCT05782647 -
Wearable Monitor in Patients With Syncope
|
N/A | |
Completed |
NCT00465439 -
Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal
|
N/A | |
Active, not recruiting |
NCT01621464 -
Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)
|
Phase 4 | |
Recruiting |
NCT06458140 -
Cardioneuroablation and Ventricular Proarrhythmia
|
N/A | |
Recruiting |
NCT06440291 -
Cardioneuroablation for Reflex Syncope and Exercise Capacity
|
N/A | |
Recruiting |
NCT06336031 -
Impact of Blood Phobia on Fainting Susceptibility
|
N/A | |
Completed |
NCT01617616 -
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
|
N/A | |
Recruiting |
NCT05086679 -
Compression Stockings for Treating Vasovagal Syncope Trial
|
N/A | |
Completed |
NCT04772755 -
Presyncope (Syncope) Prevention Study
|
N/A | |
Completed |
NCT03533829 -
Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study
|
N/A | |
Completed |
NCT05782699 -
Detecting Syncope by an Integrated Multisensor Patch-type Recorder
|
N/A | |
Completed |
NCT01695525 -
Influence of Yoga in Patients With Neurocardiogenic Syncope
|
Phase 0 | |
Completed |
NCT00475462 -
The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents
|
N/A | |
Completed |
NCT04972123 -
The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
|
Phase 2 |